These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35452635)

  • 21. Ocimum kilimandscharicum L. restores ovarian functions in letrozole - induced Polycystic Ovary Syndrome (PCOS) in rats: Comparison with metformin.
    Khaled N; El-Bahy AA; Radwan R; Handoussa H; AbdelMaksoud S
    Life Sci; 2019 Sep; 232():116640. PubMed ID: 31295470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Potential of Selenium Nanoparticles on Letrozole-Induced Polycystic Ovarian Syndrome in Female Wistar Rats.
    Butt MA; Shafique HM; Mustafa M; Moghul NB; Munir A; Shamas U; Tabassum S; Kiyani MM
    Biol Trace Elem Res; 2023 Nov; 201(11):5213-5229. PubMed ID: 36694071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mineralocorticoid receptor blockade attenuates hyperandrogenic metabolic dysregulation in letrozole-induced PCOS rat model.
    Uhunmwangho EG; Oniyide AA; Areloegbe SE; Soetan OA; Akintayo CO; Aturamu A; Olaniyi KS
    J Diabetes Metab Disord; 2022 Dec; 21(2):1539-1547. PubMed ID: 36404823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
    Jahan S; Abid A; Khalid S; Afsar T; Qurat-Ul-Ain ; Shaheen G; Almajwal A; Razak S
    J Ovarian Res; 2018 Apr; 11(1):26. PubMed ID: 29615083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome.
    Zhou Y; Lan H; Dong Z; Li W; Qian B; Zeng Z; He W; Song JL
    Oxid Med Cell Longev; 2022; 2022():5558599. PubMed ID: 35663203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ameliorative potential of rosmarinic acid in a rat model of polycystic ovary syndrome: Targeting MCP-1 and VEGF: A histological, immunohistochemical, and biochemical study.
    Shalaby AM; Shalaby RH; Elshamy AM; Alnasser SM; Alorini M; Jaber FA; Alabiad MA; Alshaikh ABA; Hassan SMA; Aziz SAMA; Safa MA; Elkholy MR
    Cell Biochem Funct; 2024 Jun; 42(4):e4073. PubMed ID: 38863227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.
    Hong Y; Yin Y; Tan Y; Hong K; Zhou H
    Med Sci Monit; 2019 Jan; 25():395-401. PubMed ID: 30636259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats.
    Ibrahim YF; Alorabi M; Abdelzaher WY; Toni ND; Thabet K; Hegazy A; Bahaa HA; Batiha GE; Welson NN; Morsy MA; Venugopala KN; Abdel-Aziz AM
    Biomed Pharmacother; 2022 May; 149():112870. PubMed ID: 35367769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patuletin Ameliorates Inflammation and Letrozole-Induced Polycystic Ovarian Syndrome in Rats.
    Shah SF; Noorali S; Faizi S; Jabeen A
    Cell Biochem Funct; 2024 Sep; 42(7):e4123. PubMed ID: 39294896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway.
    Ma X; Li X; Ma L; Chen Y; He S
    Bioengineered; 2021 Dec; 12(1):7215-7223. PubMed ID: 34546841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole.
    Lang Q; Yidong X; Xueguang Z; Sixian W; Wenming X; Tao Z
    PLoS One; 2019; 14(6):e0217495. PubMed ID: 31170164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome.
    Wang Y; Xiao H; Liu Y; Tong Q; Yu Y; Qi B; Bu X; Pan T; Xing Y
    Front Endocrinol (Lausanne); 2022; 13():891297. PubMed ID: 36017323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS).
    Atef MM; Abd-Ellatif RN; Emam MN; Abo El Gheit RE; Amer AI; Hafez YM
    Arch Biochem Biophys; 2019 Aug; 671():245-254. PubMed ID: 31251923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats.
    Ullah A; Jahan S; Razak S; Pirzada M; Ullah H; Almajwal A; Rauf N; Afsar T
    J Ovarian Res; 2017 Sep; 10(1):62. PubMed ID: 28915843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.
    Wang M; Zhao D; Xu L; Guo W; Nie L; Lei Y; Long Y; Liu M; Wang Y; Zhang X; Zhang L; Li H; Zhang J; Yuan D; Yue L
    Metabolism; 2019 May; 94():47-58. PubMed ID: 30768966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ameliorative effect of sesame oil on experimentally induced polycystic ovary syndrome: A cross-link between XBP-1/PPAR-1, regulatory proteins for lipogenesis/steroids.
    Elshamy AM; Shatat D; AbuoHashish NA; Safa MAE; Elgharbawy N; Ibrahim HA; Barhoma RAE; Eltabaa EF; Ahmed AS; Shalaby AM; Alabiad MA; Alorini M; Ibrahim RR
    Cell Biochem Funct; 2023 Mar; 41(2):268-279. PubMed ID: 36810739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance.
    Xie Y; Xiao L; Li S
    Front Endocrinol (Lausanne); 2021; 12():701590. PubMed ID: 34484117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vitamin D on experimental model of polycystic ovary syndrome in female rats.
    Helal BAF; Ismail GM; Nassar SE; Zeid AAA
    Life Sci; 2021 Oct; 283():119558. PubMed ID: 33930367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Beneficial Effects of
    Lee YZ; Cheng SH; Lin YF; Wu CC; Tsai YC
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone.
    Adeyanju OA; Falodun TO; Fabunmi OA; Olatunji LA; Soladoye AO
    Chem Biol Interact; 2019 Sep; 310():108742. PubMed ID: 31295448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.